Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
Clinical trial registration, sponsored by University Health Network, Toronto, registered 15 Sep 2026.
Phase 2 · not yet recruiting · n = 46
Tags: Registry, Psilocybin, Cancer.
Newly registered RCT of psilocybin with existential-attachment therapy in advanced cancer, 25 mg versus 1 mg, at UHN Toronto
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)
Read the original